Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Carbohydrate Metabolism

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...

Mitochondria

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Design of DEVOTE (Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events) - DEVOTE 1.

American heart journal·2016

Same author

The Impact of Nocturnal Hypoglycemia on Sleep in Subjects With Type 2 Diabetes.

Diabetes care·2015

Same author

Efficacy and Safety of Insulin Degludec 200 U/mL and Insulin Degludec 100 U/mL in Patients with Type 2 Diabetes (Begin: Compare).

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2014

Same author

Increased intrinsic mitochondrial function in humans with mitochondrial haplogroup H.

Biochimica et biophysica acta·2013

Same author

Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly.

Diabetes·2012

Same author

Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals.

Proceedings of the National Academy of Sciences of the United States of America·2011

Search research articles

Related Experiment Video

Updated: Jun 3, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Mitochondrial function in skeletal muscle in type 2 diabetes.

Rasmus Rabøl¹

¹Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Denmark. rasmus.rabol@dadlnet.dk

Danish Medical Bulletin

|April 7, 2011

Summary

Skeletal muscle mitochondrial dysfunction may cause type 2 diabetes. This research investigates pharmacological effects on mitochondrial function and explores weight gain mechanisms linked to antidiabetic treatments.

More Related Videos

Measurement of Mitochondrial Respiration in Human and Mouse Skeletal Muscle Fibers by High-Resolution Respirometry

Measurement of Mitochondrial Respiration in Human and Mouse Skeletal Muscle Fibers by High-Resolution Respirometry

Published on: October 4, 2024

Static Strength Training Method for Type 2 Diabetic Mice

Static Strength Training Method for Type 2 Diabetic Mice

Published on: March 29, 2024

Related Experiment Videos

Last Updated: Jun 3, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Measurement of Mitochondrial Respiration in Human and Mouse Skeletal Muscle Fibers by High-Resolution Respirometry

Measurement of Mitochondrial Respiration in Human and Mouse Skeletal Muscle Fibers by High-Resolution Respirometry

Published on: October 4, 2024

Static Strength Training Method for Type 2 Diabetic Mice

Static Strength Training Method for Type 2 Diabetic Mice

Published on: March 29, 2024

Area of Science:

Metabolic disorders
Mitochondrial biology
Endocrinology

Background:

Reduced skeletal muscle mitochondrial function is linked to insulin resistance and type 2 diabetes.
Oxidative capacity is lower in type 2 diabetes patients, potentially causing lipid accumulation and impaired insulin signaling.
The causal relationship between mitochondrial dysfunction and type 2 diabetes remains unclear.

Purpose of the Study:

To investigate the impact of pharmacological interventions on skeletal muscle mitochondrial function in type 2 diabetes.
To determine if mitochondrial function is uniformly distributed across upper and lower extremities.
To propose a molecular mechanism for weight gain associated with antihyperglycemic treatments.

Main Methods:

Pharmacological interventions were applied to assess effects on mitochondrial function.
Mitochondrial function was compared between upper and lower extremities.
Analysis of molecular mechanisms related to weight gain from antihyperglycemic therapies.

Main Results:

The study details the effects of various pharmacological treatments on mitochondrial function in type 2 diabetes.
Findings address the distribution of mitochondrial function in different body parts.
A hypothesis regarding the molecular basis of weight gain with antihyperglycemic drugs is presented.

Conclusions:

Pharmacological interventions can modulate skeletal muscle mitochondrial function in type 2 diabetes.
Mitochondrial function may not be uniform across all limbs.
Understanding these mechanisms can inform future diabetes management and treatment strategies.